Bleeding Symptoms of Carriers of Hemophilia A and B
NCT01029808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126
Last updated 2016-10-19
Summary
To collect and analyze data on female carriers of severe and moderate hemophilia A and B.
Conditions
Sponsors & Collaborators
-
Sahlgrenska University Hospital
lead OTHER
Principal Investigators
-
Fariba Baghaei, MD PhD
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- Sweden
Study Locations
More Related Trials
-
Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
NCT03287999 ·Status: UNKNOWN
-
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
NCT00178607 ·Status: COMPLETED
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Hemophilia Inhibitor Genetics Study (HIGS)
NCT00166387 ·Status: COMPLETED
-
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 ·Status: COMPLETED
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
NCT03276130 ·Status: COMPLETED
-
Socialization of Adult Men With Congenital Hemophilia A or B
NCT01510418 ·Status: COMPLETED
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
NCT01988532 ·Status: COMPLETED
-
Data Registry in Chinese Hemophilia A and B Patients
NCT07101224 ·Status: COMPLETED
-
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
NCT02568202 ·Status: COMPLETED
-
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
NCT01386528 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children
NCT02999308 ·Status: UNKNOWN ·Phase: PHASE4
-
Learning to Live With Non-severe Haemophilia
NCT05314751 ·Status: COMPLETED
-
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295 ·Status: COMPLETED
-
Biomarkers Serum Collection Methodology Pilot Study
NCT01318707 ·Status: COMPLETED
-
Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
NCT02971969 ·Status: COMPLETED
-
World Bleeding Disorders Registry Pilot Study
NCT02776826 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862 ·Status: COMPLETED
-
Project to Update the Study of Congenital Haemophilia in Spain
NCT01959555 ·Status: COMPLETED
-
A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A
NCT02920398 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A
NCT02035384 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
NCT01480180 ·Status: COMPLETED ·Phase: PHASE3